Andrej Kováčik

Dr. Andrej Kováčik

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
AKAndrej Kováčik
Andrej Kováčik
MKMonika Kopečná
Monika Kopečná
KVKaterina Vavrova
Katerina Vavrova
Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed. Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations. Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.

21 August 2014 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
BŠBarbora Školová
Barbora Školová
KHKlára Hudská
Klára Hudská
PPPetra Pullmannová
Petra Pullmannová
AKAndrej Kováčik
Andrej Kováčik
KPKarel Palát
Karel Palát
KVKaterina Vavrova
Katerina Vavrova

1 May 2017 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
BŠBarbora Školová
Barbora Školová
AKAndrej Kováčik
Andrej Kováčik
OTOndřej Tesař
Ondřej Tesař
LOLukáš Opálka
Lukáš Opálka
KVKaterina Vavrova
Katerina Vavrova

1 May 2017 in Biophysical Chemistry
Verified
Journal Article
Closed access
PPPetra Pullmannová
Petra Pullmannová
LPLudmila Pavlíková
Ludmila Pavlíková
AKAndrej Kováčik
Andrej Kováčik
MSMichaela Sochorová
Michaela Sochorová
BŠBarbora Školová
Barbora Školová
KVKaterina Vavrova
Katerina Vavrova

1 November 2015 in Journal of Dermatological Science
Verified
Journal Article
Closed access
LWLeonie Wallmeyer
Leonie Wallmeyer
DLDominika Lehnen
Dominika Lehnen
NENatascha Eger
Natascha Eger
MSMichaela Sochorová
Michaela Sochorová
LOLukáš Opálka
Lukáš Opálka
SHSarah Hedtrich
Sarah Hedtrich

10 November 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MJMartin Juhaščik
Martin Juhaščik
AKAndrej Kováčik
Andrej Kováčik
Gloria Huerta-ÁngelesGloria Huerta-Ángeles
Gloria Huerta-Ángeles
Hyaluronan (HA) plays a fundamental role in maintaining the homeostasis on skin health. Furthermore, the effect of HA in skin inflammatory diseases is worth studying in the next future. HA and its conjugates change the solubility of active pharmaceutical ingredients, improve emulsion properties, prolong stability, reduce immunogenicity, and provide targeting. HA penetrates to deeper layers of the skin via several mechanisms, which depend on the macromolecular structure and composition of the formulation. The cellular and molecular mechanisms involved in epidermal dysfunction and skin aging are not well understood. Nevertheless, HA is known to selectively activate CD44-mediated keratinocyte signaling that regulates its proliferation, migration, and differentiation. The molecular size of HA is critical for molecular mechanisms and interactions with receptors. High molecular weight HA is used in emulsions and low molecular weight is used to form nanostructured lipid carriers, polymeric micelles, bioconjugates, and nanoparticles. In the fabrication of microneedles, HA is combined with other polymers to enhance mechanical properties for piercing the skin. Hence, this review aims to provide an overview of the current state of the art and last reported ways of processing, and applications in skin drug delivery, which will advocate for their broadened use in the future.